Radiolabeling of zoledronic acid with 188Re as a new palliative agent radiotracer in treatment of bone tumors

Zoledronic acid is a bisphosphonates to treat bone problems. Rhenium-188-zoledronic acid could be used as a palliate agent in skeletal metastases. Radiolabeled product was prepared through optimized radiochemical procedures. The organs uptake especially bone uptake assessed in healthy animals mice. The radiochemical purity of the radiotracer was > 95% which was stable up to 24 h. Bone uptake (1.08?±?0.14% ID/g at 1 h) with retention of activity in bone up to 24 h (0.26?±?0.06% ID/g) was reached. This radiotracer can be used as a developing candidate for a palliative treatment of bone metastasis.